The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases

Journal of Cellular and Molecular Medicine, 2021-02, Vol.25 (3), p.1342-1349 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16239 ;PMID: 33443816

Digital Resources/Online E-Resources